Analyst Consensus ?
ConsensusBuy43 ratings
Bullish2353.5%
Neutral1841.9%
Bearish24.6%
FN2 Earnings Intelligence
Chubb Limited (CB) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 20, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Neutral | Neutral | Maintain | Sep 16, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 19, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 23, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 22, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 10, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 8, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 8, 2026 |
| HSBC | Hold | Buy | Downgrade | Jul 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jun 12, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Apr 14, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 23, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 10, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Feb 9, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 9, 2026 |
| Roth Capital | Buy | Buy | Maintain | Feb 4, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jan 8, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 22, 2025 |
| Jefferies | Hold | Hold | Maintain | Apr 11, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 30, 2025 |
| Roth MKM | Buy | Buy | Maintain | Jul 24, 2024 |
| William Blair | Underperform | Market Perform | Downgrade | Jun 28, 2024 |
| MKM Partners | Buy | Buy | Maintain | Dec 5, 2022 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 15, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 1, 2021 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 17, 2021 |
| Argus Research | Buy | Hold | Upgrade | Jul 30, 2021 |
| Compass Point | Neutral | Buy | Downgrade | May 29, 2019 |
| Sandler O'Neill | Hold | Buy | Downgrade | Apr 3, 2019 |
| Argus | Hold | Hold | Maintain | Apr 6, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Oct 15, 2015 |
| Sterne Agee CRT | Buy | Buy | Maintain | Sep 21, 2015 |
| Bernstein | Outperform | Market Perform | Upgrade | Jul 31, 2015 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jul 24, 2015 |
| Janney Capital | Buy | Neutral | Upgrade | Jul 24, 2015 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Jul 6, 2015 |
| Nomura | Neutral | Neutral | Maintain | Apr 25, 2014 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Dec 13, 2013 |
| Miller Tabak | Hold | Buy | Downgrade | Oct 3, 2013 |
| Guggenheim | Buy | Buy | Maintain | Sep 18, 2013 |
| Sterne Agee | Buy | Buy | Maintain | Jun 26, 2012 |
Upside is calculated against the persisted current price $340.64. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Yaron Kinar | $347 | $341.86 | +1.9% | Sep 16, 2026 |
| Morgan Stanley | Bob Huang | $360 | $345.29 | +5.7% | Aug 19, 2026 |
| Wells Fargo | Analyst unavailable | $356 | $343.23 | +4.5% | Jul 23, 2026 |
| Deutsche Bank | Cave Montazeri | $354 | $341.6 | +3.9% | Jul 22, 2026 |
| Atlantic Equities | Analyst unavailable | $301 | $339.6 | -11.6% | Jul 15, 2026 |
| Piper Sandler | Analyst unavailable | $374 | $346.22 | +9.8% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $374 | $345.34 | +9.8% | Jul 10, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $337 | $355.09 | -1.1% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $352 | $355.09 | +3.3% | Jul 9, 2026 |
| UBS | Brian Meredith | $369 | $356.49 | +8.3% | Jul 8, 2026 |
| Barclays | Analyst unavailable | $387 | $356.53 | +13.6% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $340 | $361.17 | -0.2% | Jul 6, 2026 |
| HSBC | Vikram Gandhi | $373 | $361.17 | +9.5% | Jul 6, 2026 |
| Barclays | Analyst unavailable | $368 | $327.93 | +8.0% | Jun 12, 2026 |
| Wells Fargo | Elyse Greenspan | $333 | $325.43 | -2.2% | Apr 23, 2026 |
| BMO Capital | Michael Zaremski | $326 | $326.17 | -4.3% | Feb 10, 2026 |
| UBS | Analyst unavailable | $340 | $331.56 | -0.2% | Feb 9, 2026 |
| Seaport Global | Analyst unavailable | $373 | $330.7 | +9.5% | Feb 9, 2026 |
| Mizuho Securities | Analyst unavailable | $336 | $331.28 | -1.4% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $366 | $331.28 | +7.4% | Feb 5, 2026 |
| Roth Capital | Analyst unavailable | $360 | $332.15 | +5.7% | Feb 4, 2026 |
| HSBC | Analyst unavailable | $354 | $299.96 | +3.9% | Jan 16, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $301.11 | +2.7% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $317 | $300.69 | -6.9% | Jan 14, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $309 | $300.69 | -9.3% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $305 | $306.62 | -10.5% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $339 | $306.63 | -0.5% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $351 | $306.63 | +3.0% | Jan 7, 2026 |
| Evercore ISI | David Motemaden | $346 | $307.52 | +1.6% | Jan 7, 2026 |
| Morgan Stanley | Bob Huang | $310 | $312.54 | -9.0% | Dec 16, 2025 |
| Mizuho Securities | Analyst unavailable | $318 | $312.54 | -6.6% | Dec 15, 2025 |
| Goldman Sachs | Alex Scott | $309 | $281.68 | -9.3% | Oct 27, 2025 |
| UBS | Analyst unavailable | $298 | $281.02 | -12.5% | Oct 27, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $281.12 | -11.9% | Oct 27, 2025 |
| BMO Capital | Michael Zaremski | $283 | $281.16 | -16.9% | Oct 23, 2025 |
| Wells Fargo | Analyst unavailable | $293 | $276.52 | -14.0% | Oct 23, 2025 |
| Barclays | Analyst unavailable | $310 | $289.24 | -9.0% | Oct 8, 2025 |
| Evercore ISI | Analyst unavailable | $315 | $282.76 | -7.5% | Oct 1, 2025 |
| Wolfe Research | Tracy Benguigui | $320 | $274.33 | -6.1% | Sep 15, 2025 |
| Evercore ISI | David Motemaden | $312 | $270.15 | -8.4% | Jul 23, 2025 |
| Barclays | Alex Scott | $298 | $283.19 | -12.5% | Jul 7, 2025 |
| UBS | Brian Meredith | $304 | $282.18 | -10.8% | Apr 28, 2025 |
| Wells Fargo | Elyse Greenspan | $278 | $282 | -18.4% | Apr 24, 2025 |
| HSBC | Analyst unavailable | $323 | $287.01 | -5.2% | Mar 5, 2025 |
| Morgan Stanley | Michael Phillips | $300 | $283.76 | -11.9% | Oct 30, 2024 |
| Bank of America Securities | Joshua Shanker | $282 | $282.83 | -17.2% | Oct 10, 2024 |
| Bank of America Securities | Joshua Shanker | $275 | $288.54 | -19.3% | Oct 4, 2024 |
| Barclays | Alex Scott | $349 | $290.94 | +2.5% | Sep 4, 2024 |
| Bank of America Securities | Joshua Shanker | $264 | $263.25 | -22.5% | Jul 24, 2024 |
| Morgan Stanley | Bob Huang | $259 | $253.34 | -24.0% | Jul 10, 2024 |
| Evercore ISI | David Motemaden | $278 | $252.97 | -18.4% | May 16, 2024 |
| RBC Capital | Mark Dwelle | $285 | $243.01 | -16.3% | Apr 25, 2024 |
| HSBC | Vikram Gandhi | $270 | $254.79 | -20.7% | Apr 4, 2024 |
| Citigroup | Analyst unavailable | $229 | $216.25 | -32.8% | Feb 8, 2023 |
| Jefferies | Analyst unavailable | $246 | $227.18 | -27.8% | Jan 9, 2023 |
| RBC Capital | Analyst unavailable | $250 | $219.96 | -26.6% | Dec 14, 2022 |
| MKM Partners | Analyst unavailable | $260 | $216.79 | -23.7% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $220 | $211.85 | -35.4% | Nov 22, 2022 |
| Raymond James | Analyst unavailable | $260 | $184.79 | -23.7% | Jul 28, 2022 |
| Wells Fargo | Analyst unavailable | $250 | $187 | -26.6% | Jul 28, 2022 |
| Morgan Stanley | Michael Phillips | $216 | $207.31 | -36.6% | May 24, 2022 |
| Barclays | Tracy Benguigui | $249 | $204 | -26.9% | May 22, 2022 |
| Raymond James | Gregory Peters | $250 | $206.45 | -26.6% | May 1, 2022 |
| Barclays | Tracy Benguigui | $250 | $206.45 | -26.6% | Apr 30, 2022 |
| RBC Capital | Analyst unavailable | $243 | $210.62 | -28.7% | Apr 28, 2022 |
| Barclays | Tracy Benguigui | $244 | $210.52 | -28.4% | Apr 16, 2022 |
| RBC Capital | Mark Dwelle | $239 | $212.58 | -29.8% | Apr 7, 2022 |
| Goldman Sachs | Alex Scott | $237 | $206.74 | -30.4% | Feb 2, 2022 |
| Evercore ISI | David Motemaden | $233 | $207.53 | -31.6% | Feb 2, 2022 |
| Wells Fargo | Elyse Greenspan | $230 | $206.74 | -32.5% | Feb 2, 2022 |
| JMP Securities | Matthew Carletti | $225 | $195.52 | -33.9% | Jan 14, 2022 |
| Credit Suisse | Andrew Kligerman | $225 | $190.79 | -33.9% | Nov 1, 2021 |
| Bank of America Securities | Joshua Shanker | $156 | $176.91 | -54.2% | Oct 7, 2021 |
| Deutsche Bank | Phil Stefano | $170 | $162.59 | -50.1% | Jul 12, 2021 |
Track every rating change on CB the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.